Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML

Acute myeloid leukemia (AML) is a deadly heterogeneous hematologic malignancy. Despite the well-characterized genetic characteristics and new promising targeted therapies for AML, the clinical outcome remains suboptimal. Galectin-9 (Gal-9) is a good potential target due to its immunosuppressive capa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Zhang, Yongping, Xue, Song, Hao, Qi, Liu, Fuhong, Huang, Wenqiu, Wang, Jingbo
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2021
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176406/
https://ncbi.nlm.nih.gov/pubmed/34093826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.53686
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki